Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Uniswap activated its fee switch today, enabling on-chain UNI buybacks funded by protocol fees. The move links revenu...
A sharp 36% February drop put Lemonade in the spotlight. This guide breaks down what happened, how the AI-driven grow...
This in-depth look breaks down Summit Midstream's 2025 earnings trajectory, cash-flow health, and strategic bets. Lea...
Rocket Lab stock surged on upbeat results and new contracts, signaling renewed investor interest. This guide breaks d...
Shimmick's Q1 2026 results offer a window into infrastructure demand and cost pressures. This article breaks down the...
Investors are hearing bold predictions about rapid crypto gains. This article breaks down how such moves could happen...
Mortgage REITs like AGNC regularly issue new shares to manage leverage and fund income opportunities. This article ex...
In May, walmart stock dropped 12% despite solid earnings. This in-depth look breaks down the drivers behind the decli...
Global demand for AI-enabled services meets market volatility. This guide breaks down Globant's strategy, risks, and ...
A large insider stake in Veris Residential stock signals conviction from an established manager. This article explain...
As Cognyte readies its Q1 2027 earnings report, investors want clarity on growth, margins, and cash flow. This guide ...